Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHO: Gemcitabine and Cetuximab in Advanced Biliary Tract Cancer
NCT00747097Phase 2Completed
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in biliary tract cancer (BTC). Started Sep 2008; status: completed.
02
Drugs
cetuximab
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00747097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747097.